|
Endo Pharmaceuticals Holdings Inc. - SWOT AnalysisPublished by: Datamonitor Published: Jun. 4, 2008 - 26 Pages Table of Contents
AbstractDatamonitor's Endo Pharmaceuticals Holdings Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.Endo Pharmaceuticals (Endo) engages in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used for the treatment and management of pain. The company primarily operates in the US. Endo is headquartered in Chadds Ford, Pennsylvania and employs about 1,000 people. The company recorded revenues of $1,085.6* million during the fiscal year ended December 2007, an increase of 19.3% over 2006. The operating profit of the company was $317.2 million during fiscal year 2007, an increase of 50.7% over 2006. The net profit was $227.4 million in fiscal year 2007, an increase of 65% over 2006. *Financials are unaudited http://phx.corporate-ir.net/phoenix.zhtml?c=123046&p=irol-newsArticle&ID=1111324&highlight= Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||